Coronary artery disease in patients with HIV infection

Amish A Patel1, Matthew J Budoff

  • 1Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 W Carson St, Torrance, CA, 90502, USA.

Insights

Human immunodeficiency virus (HIV) infection increases the risk of early coronary artery disease due to chronic inflammation and antiretroviral therapy. Early detection and prevention strategies are crucial for managing cardiovascular risk in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection is now a chronic condition due to effective antiretroviral therapy (ART).
  • HIV-infected individuals face an elevated risk of premature coronary artery disease (CAD).
  • This increased cardiovascular risk is attributed to traditional risk factors, ART, and persistent chronic inflammation.

Purpose of the Study:

  • To conduct a comprehensive literature review on the relationship between HIV infection and atherosclerosis.
  • To highlight the emerging concern of premature cardiovascular disease in the HIV-positive population.
  • To emphasize the need for early detection and aggressive prevention strategies for cardiovascular risk in HIV patients.

Main Methods:

  • Systematic review of existing medical literature.
  • Analysis of studies focusing on HIV, atherosclerosis, and cardiovascular risk factors.
  • Synthesis of data regarding the impact of ART and chronic inflammation on cardiovascular health in HIV patients.

Main Results:

  • HIV infection accelerates the development of atherosclerosis and plaque progression.
  • Long-term use of antiretroviral therapy (ART) contributes to cardiovascular risk.
  • Chronic inflammation associated with HIV infection plays a significant role in premature CAD.

Conclusions:

  • HIV-infected patients are at high risk for premature coronary artery disease.
  • Early identification of subclinical atherosclerosis is essential in this population.
  • Multidisciplinary teams must implement aggressive primary and secondary cardiovascular prevention strategies for HIV patients.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
592
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
803
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482